Rocket Pharmaceuticals (RCKT) P/E (2015 - 2026)
Rocket Pharmaceuticals (RCKT) P/E from Jun 30, 2015 to Jul 21, 2026. The TTM Rocket Pharmaceuticals (RCKT) P/E is -1.76. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Rocket Pharmaceuticals (RCKT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.76 | +3.80% |
| 2025 | -1.69 | -62.93% |
| 2024 | -4.57 | -53.14% |
| 2023 | -9.76 | +51.07% |
| 2022 | -6.46 | -21.41% |
| 2021 | -8.22 | -63.63% |
| 2020 | -22.60 | +75.66% |
| 2019 | -12.86 | +55.98% |
| 2018 | -8.25 | -93.44% |
| 2017 | -125.77 | +635.00% |
| 2016 | -17.11 | -2.79% |
| 2015 | -17.60 | N/A |
Comparison Rocket Pharmaceuticals (RCKT) P/E with competitors
Rocket Pharmaceuticals (RCKT) P/E is -1.76.